Recent News

• 03.07.2025 - Atara Biotherapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Operational Progress
• 02.07.2025 - Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 01.21.2025 - Atara Biotherapeutics Provides Update on Clinical Programs Related to EBVALLO™ (tabelecleucel) and ATA3219
• 01.16.2025 - Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLO™ (tabelecleucel)

Recent Filings

• 03.07.2025 - EX-99.1 EX-99.1
• 03.07.2025 - 8-K Current report
• 03.07.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.03.2025 - 144 Report of proposed sale of securities
• 03.03.2025 - 8-K Current report
• 03.03.2025 - 144 Report of proposed sale of securities
• 03.03.2025 - 144 Report of proposed sale of securities